$AMBC bottom Pr
$0.13
ABMC Launches New Rapid Drug Test for K2
Business Wire (Tue 10:00AM EST)
Website
Shares Outstanding: 26.03M
Float: 19.30M
% Held by Insiders: 25.27%
% Held by Institutions: 1.10%
Shares Short (as of Aug 31, 2009): 5.14K
Short Ratio (as of Aug 31, 2009): 0.09
Short % of Float (as of Aug 31, 2009): N/A
Shares Short (prior month): 5.86K
Headlines
American Bio Medica Corporation develops, manufactures, and sells immunoassay tests for the immediate point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. The company provides urine-based POCT products that comprise Rapid Drug Screen to detect the presence or absence of 2 to 10 DOA; Rapid ONE for testing the presence or absence of a single DOA; RDS InCup, which detects the presence or absence of 2 to 12 DOA; Rapid TOX that detects the presence or absence of 2 to 10 DOA; and Rapid TOX Cup II for detecting the presence or absence of 2 to 14 DOA. Its urine-based POCT products test various drugs, including amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, MDMA, methadone, methamphetamines, opiates, oxycodone, phencyclidine (PCP), propoxyphene, marijuana (THC), and tricyclic antidepressants. The company also offers oral fluid based POCT products comprising OralStat that test amphetamines, barbiturates, benzodiazepines, cocaine, MDMA, methadone, methamphetamines, opiates, PCP, propoxyphene, and THC drugs to detect DOA. In addition, it distributes Rapid Reader, a compact portable unit, which uses a camera to capture a picture of the results obtained when using an ABMC POCT product; and POCT products to detect the presence or absence of adulterants and alcohol. Further, the company offers bulk strip contract manufacturing services to various non-affiliated POCT diagnostic companies. American Bio Medica Corporation serves workplace, government, clinical/pain management, rehabilitation/drug treatment, and education markets directly, as well as through distributors in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.
$0.13
ABMC Launches New Rapid Drug Test for K2
Business Wire (Tue 10:00AM EST)
Website
Shares Outstanding: 26.03M
Float: 19.30M
% Held by Insiders: 25.27%
% Held by Institutions: 1.10%
Shares Short (as of Aug 31, 2009): 5.14K
Short Ratio (as of Aug 31, 2009): 0.09
Short % of Float (as of Aug 31, 2009): N/A
Shares Short (prior month): 5.86K
Headlines
American Bio Medica Corporation develops, manufactures, and sells immunoassay tests for the immediate point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. The company provides urine-based POCT products that comprise Rapid Drug Screen to detect the presence or absence of 2 to 10 DOA; Rapid ONE for testing the presence or absence of a single DOA; RDS InCup, which detects the presence or absence of 2 to 12 DOA; Rapid TOX that detects the presence or absence of 2 to 10 DOA; and Rapid TOX Cup II for detecting the presence or absence of 2 to 14 DOA. Its urine-based POCT products test various drugs, including amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, MDMA, methadone, methamphetamines, opiates, oxycodone, phencyclidine (PCP), propoxyphene, marijuana (THC), and tricyclic antidepressants. The company also offers oral fluid based POCT products comprising OralStat that test amphetamines, barbiturates, benzodiazepines, cocaine, MDMA, methadone, methamphetamines, opiates, PCP, propoxyphene, and THC drugs to detect DOA. In addition, it distributes Rapid Reader, a compact portable unit, which uses a camera to capture a picture of the results obtained when using an ABMC POCT product; and POCT products to detect the presence or absence of adulterants and alcohol. Further, the company offers bulk strip contract manufacturing services to various non-affiliated POCT diagnostic companies. American Bio Medica Corporation serves workplace, government, clinical/pain management, rehabilitation/drug treatment, and education markets directly, as well as through distributors in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.
